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 Oscimum sanctum is herbal that was spread widely in Indonesia. Oscimum 
sanctum contains abundant of substances. One of the functions on 
Oscimum sanctum was anti-thrombocytes effect. This effect is associated 
with platelet function as a mechanical plug in the vascular injury during the 
normal homeostatic response. The disruption in thrombocytes function leads 
to disturb the blood clotting process. Therefore, The aims of the research 
were to prove the impact of Oscimum sanctum on the number of 
thrombocytes. This research used mice that divided into 3 groups, as a group 
I dose 250 mg/day (Oscimum sanctum infusion), group II dose 500 mg/day 
and the control group. We used clopidogrel as a positive control to determine 
the effectiveness of anti platelet effect. Data were analyzed by ANOVA 
showed that the existence of anti-thrombocyte effect in the Oscimum 
sanctum dose 500 mg/day was significantly different. This result proved that 
Oscimum sanctum has anti-thrombocytes effect by decreasing thrombocytes 
number. 
Keyword: 
Oscimum sanctum 
Clopidogrel 
Thrombocytes number 
Copyright © 2016 Institute of Advanced Engineering and Science.  
All rights reserved. 
Corresponding Author: 
Yoni Astuti, 
Biochemistry  Department of Medical and Health Sciences, 
Universitas Muhammadiyah Yogyakarta, Indonesia. 
Email : yoni_astuti@yahoo.co.id 
 
 
1. INTRODUCTION 
Oscimum sanctum are found everywhere in Indonesia. Oscimum sanctum has many functions 
including as food and traditional medicine, event Indonesian people use Oscimum sanctum more often as 
food than traditional medicine. In the health sciences Oscimum sanctum used to cure cough, to decrease heat 
of the body, anti-diarrhea, to cure insect bite, to make comfort during menstruation [1]. 
Oscimum sanctum contains eugenol, cineol, osimen, pinene, terpinhydrate, methyl chavicol, 
linalool, anethole, thymol, camphor, alanine, arginine, ascorbic acid, aspartic acid, benzyl acetate, β-carotene, 
β-sitosterol, Caffeic acid, carbohydrate, copper, cystine, eriodictyol, aesculetin, aeskulin, fat, fiber, geranyl 
acetate, glutamic acid, glycine, histidine, isoleucine, isoquercetin, leucine, lysine, magnesium, methionine, 
mersin, niacin, p-Coumaric acid, phytosterols, potassium, proline, quercetin, riboflavin, ruti, thiamine, 
tryptophan, tyrosine, valine, calcium, phosphorus, ferro and sulfur [2]. The substances have a function as 
medicine in Oscimum sanctum were essential oil, was found as dominant substances [3]. 
Currently, abundant reports were carried out to explore the substances and the function of Oscimum 
sanctum. In India, Oscimum sanctum were recommended to cure bronchitis, diarrhea, asthma bronchial, 
malaria, dysentery, dermatitis, arthritis, eye diseases, fever, insect bite, hepatoprotective, anticancer, 
antidiabetic, antispasmodic, antifungal, antimicrobial, analgesic, adaptogenic, antifertility, antiemetic, 
cardioprotective, diaphoretic [3]. Some reports were found that Oscimum sanctum have anti aggregasion 
trombocyes effect [3]-[6]. The effect was associated with the function of thrombocytes as a mechanical  plug 
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if vascular inflammatory occurred to respond normal homeostatis [7]. Disruption of thrombocytes 
aggregation leads to the clotting blood disturbances. 
Ocimum basilicum is a family to Oscimum sanctum. This plant has substances similar with 
Oscimum sanctum but the concentration was different. Oscimum sanctum has an anti aggregation of 
thrombocytes effect. This effect was associated with the obstacle of thrombus generation regarding to 
thrombus malfunction [2],[4]. This study was conducted to prove the function of Oscimum sanctum, a family 
with Ocimum basilicum as resistor to the thrombocytes aggregation. How Oscimum sanctum interfere the 
number of thrombocytes was important to know to support the holistic medical. 
 
 
2. RESEARCH METHOD 
 
2.1. Grouping the subject 
Sixteen male mice of swiss strain, ± 20 grams body weight, 2 months old, were divided into 3 
groups to treat with Oscimum sanctum infusion in different dose during 10 days. The aclimatitation for mice 
was a week.  Groups 1 and  2 were treated  as follows 250 mg/day, 500 mg/ day. Group 3 was positive 
control, treating by clopidogrel (1.35 mg/day). The blood was collected from mice tails 0.5 ml at day 0 and 
day 10
th
. The research was conducted at Animal Laboratoy of Medical and Health Sciences of Universitas 
Muhammadiyah Yogyakarta. 
 
2.2. Thrombocyt  analyses  
Thrombocytes number was detected by blood hematology analyzer at laboratorium penelitian dan 
pengujian terpadu  (LPPT) Universitas Gadjah Mada. The calculation of thrombocyte number based on  the 
phase-contrast methods. The calculation was repeated 5 times. 
 
2.3. Infusion preparation 
Twenty five grams Oscimum sanctum simplicia was heated into 150 ml water (90º C). After 15 
minutes was cooled down.Water was filtered to seperate from the leaf. This infusa was 250 mg/ml. The 
similar way to prepare 500 mg/ ml of infusa, with the weight of simplicia 50 gr.  
 
2.4. Statistical analyses  
Data are presented as mean ± SD. Comparisons between the control and the treatment groups also 
statistical significance were performed by using one-way ANOVA. Statistical significance was set upon p < 
0.05. 
 
 
3. RESULTS AND ANALYSIS 
There is a decreasing of thrombocytes number after treating with Oscimum sanctum infusion. The 
average of thrombocytes number at day 0 and day 10
th
 is shown in Table 1. 
 
 
Table 1.The Average of Thrombocytes Number at Day 0 and Day 10
th 
after Treating 
with Oscimum sanctum Infusion 
Groups (dose of Oscimum sanctum) Thrombocyte number at day 0 (x±SD) 
Thrombocyte number 
at day 10 th (x±SD) 
Decreasing 
Number 
P value 
Groups 1 : 250 mg/day 840000±352772 828500±351771 11500 0.546 
Groups 2:  500 mg/day 874250±308298 775250±335808 99000 0.07 
Groups 3:clopidogrel (1,35 mg/day). 1043500±217493 595000±311683 448500 0.04* 
P< 0.05 ,*, significant different, between day 0 and day 10th 
 
 
Table 1 shows that the highest on decreasing of thrombocytes number is clopidogrel group. Dose 
500mg/ day has higher effect than dose 250 mg/day. The decreasing of the thrombocyte number on dose 250 
mg/ day was not significant statistically, but the Oscimum sanctum has an effect on the decreasing 
thrombocyte number. The clopidogrel was significant decreasing the thrombocytes number (P< 0.005). This 
study found that Oscimum sanctum infusion and clopidogrel have a function to decrease thrombocytes 
number. In dose more than 500mg/ day, probably has the same potentiality to clopidogrel. In this research 
showed that dose 500mg/day has lower potentiality to the standard dose, clopidogrel. Perhaps, the 
potentiality will be similar if the dose higher than 500mg/day. 
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Percentage on decreasing thrombocytes number is linear to the dose of Oscimum sanctum infusion, 
more dose of Oscimum sanctum more decrease on thrombocyte number. Table 2 shows  the potentiality of 
infusion Oscimum sanctum and clopidogrel to decrease the number of thrombocyte during 10 days . 
 
Table 2. Potentiality of Infusion Oscimum sanctum and Clopidogrel on the Decreasing Thrombocyte Number 
 
 
 
 
 
 
The dose 500 mg/day has 13,84 % and the dose 250 mg/day has much lower 1.52%. Clopidogrel as 
a control has 45.72%. This study used clopidogrelas positive control. Clopidogrel hydrogen sulfate, methyl 
(+)-(S)-α-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-acetate hydrogen sulfate, is a novel 
thienopyridine derivative that irreversibly blocks adenosine diphosphate (ADP) and is important in platelet 
aggregation, the cross-linking of platelets by fibrin [8]. Clopidogrel as a standard medicine for anti 
thrombocyte was common in public markets. Beside that, clopidogrel was compare with Oscimum sanctum 
infusion because both showed the effect after 7 days [3],[5],[9]. 
The comparison between potentiality of Oscimum sanctum infusion to clopidogrel has shown in 
Table 3. The potentiality of infusion in 500mg/ day has 22.2% t and 250 mg/day 0.026% to clopidogrel. It 
was shown that the function will be significant with dose more than 500 mg/ ml. There was no meaning with 
dose less than 250 mg/ml. 
 
 
Table 3. Comparasion of the Potentiality Oscimum sanctum Infusion to Clopidogrel on Decreasing 
Thrombocyte Number 
Groups Percentage (%) thrombocytes number 
Group 1: 250mg/day / clopidigrel 2.5641 
Group 2:500mg/day/clopidogrel 22.07358 
 
 
Table 3 describes that double dose of Oscimum sanctum infusion compare to clopidogrel  result in 
effect around 10 times stronger on decresing trombocytes number. But it does not mean that 1000mg/day 
Oscimum sanctum infusion will has effect 100 times stronger than 250 mg/day. 
Since Singh et al, 2007 reported that oil of Oscimum sanctum has the effect of anticoagulant by 
inhibition of TXA2 through cyclooxygenase and produces PGI3 and TXA3. Like PGI2, PGI3 have 
antiaggregatory property while TXA3 has much less antiaggregatory. Thus, both of subtances work 
concurrently to contribute the anticoagulant effect on oil of oscium sanctum
4
. We use infusion because the 
substances of infusion more complete and the concentration higher. Eugenol in Oscimum sanctum was 40% 
[1],[3] and able to obstruct thrombocytes agreggration by inhibition on arachidonat acid, collagen, 
epinephrine, ADP to induce thrombocytes aggregation [10]. The inhibition on such ways leads to inhibit on 
the increasing of collagen, ADP and Ca
2+ 
as regulatoron the function of thrombocytes. 
The thrombocytes regulator substances were divided into 3 groups. Collagen was the first agents 
that formed outside of thrombocytes and interact with receptors on thrombocyte membrane. ADP was second 
groups as agent that formed inside of thrombocytes and interact with receptors membrane, meanwhile the 
Ca
2+
as the third group as agent that formed inside of thrombocytes and work inside [7]. In this situation if the 
vascular endothel damage, ADP did not invole in the increasing of thrombocytes aggregation. Nevertheless 
thrombocytes aggregation still occurred, thrombocyt did not produced signalling substances on fibrin 
formation to encourage thrombocytes plug that already avaiabled and also collagen was hampered to act as a 
mark on fibrin formation.With the result that thrombocytes in blood will be reduced which causes bleeding 
time longer. 
The other report showed that Oscimum sanctum also contains of methanolic substances that have an 
antiatherogenic effect, as called Caps HT2 or HT2 blocker. Caps HT2 has a function as an antioxidant, 
anticoagulant, antiageggration of thrombocytes, releasing lipoprotein lipase, anti-inflammation agent, and 
activate of hipolipidemic on mice [6]. Oscimum sanctum also have flavonoids. as shown in Melothria 
maderaspatana. Methanolic and flavonoid were extracted with hexane able to inhibit thrombocyte 
aggregation [11]. It was assumed that the effect of thrombocytes aggregation due to methanolic and 
flavonoids activity. The mechanism as antiagreggation on thrombocyt by methanolic was poor understood. 
Whereas the mechanism of flavonoids on the inhibition of thrombocytes was mediated with the increasing of 
Groups ( dose of b Oscimum sanctum infusion) 
Decreasing number 
(x±SD) 
Percentage of decreasing 
number  (%) 
Dose:  250 mg/day 11500±4796 1.52±1 
Dose: 500 mg/day 99000±29944 13.84±10 
Clopidogrel 448500±0 45.72±18 
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cyclic AMP (platelets' cyclic AMP levels) by stimulate adenylate cyclase also inhibited cAMP 
phosphodiesterase [6].  
Flavonoids impede the adhesion and ageggration of thrombocytes, beside of releasing the calcium 
sitoplasmic to stimulate the releasing of ADP and 5HT. Serotonin (5HT) was released by thrombocyte to 
stimulate ageggration and vasoconstriction [10]. The inhibition on this mechanism by flavonoid, result in the 
inhibition of thrombocytes ageggration due to the inhibition from eugenol also. The inhibition on 
vasoconstriction induced to the complicacy on thrombocytes plug formation, lead to the bleeding time longer. 
The similar effect made by eugenol. Wherefore the inhibition of thrombocyte aggregation by eugenol, 
methanolic and flavonoid induced in the decreasing of thrombocyte number. Perhaps, this mechanism results 
in the execcive of thrombus formation inhibition by the adhesion and thrombocytes aggregation. This study 
showed that Oscimum sanctum have a function as an alternative anti thrombocytes medicine [10]. 
 
 
4. CONCLUSION 
Oscimum sanctum have a thrombocytes anti ageggrations by lowering the thrombocytes number. 
The dose of Oscimum sanctum more than 500mg/day could have the similar effect to clopidogrel on the 
lowering of thrombocytes number. Oscimum sanctum could as the alternative medicine as the thrombocytes 
anti ageggration.We suggest for further research: (1) to explore the higher dose of Oscimum sanctum infusion 
more than 500 mg/ day to find the similar potentiality with standard dose on clopidogrel, (2) to explore the 
other liquid than water to extract Oscimum sanctum to produce the concentrated extraction, (3) the 
mechanisme of decreasing the thrombocyt number still need explrored. 
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